For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and MIDAS scores.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda (R)) Lexaria has now demonstrated, in distinct human clinical ...

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with migraines ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...